Dyslipidaemia Guidelines
Published: 07 February 2020
-
Views:
209
-
Likes:
7
-
Views:
209
-
Likes:
7
-
Up Next
-
8m 2sPart 1 Lipid-lowering strategies Lale Tokgözoğlu
-
4m 47sPart 2 Combination therapy François Mach
Overview
A short series of talks covering Dyslipidaemia Guidelines, focusing on Lipid-lowering strategies, combination therapy and key updates.
These videos were funded by Mylan.
Educational objectives
- To educate cardiovascular physicians on the recent ESC guidelines on dyslipidaemia management
- Understand key changes to dyslipidaemia guidelines and apply practical cost-effective therapies to meet lipid targets
- Understand the benefits in utilisation of combination products to meet targets
- Increase awareness of the availability of combination products
More from this programme
Part 1
Lipid-lowering strategies
In this video, Prof S Lale Tokgözoglu (Hacettepe University, Ankara, TR) discusses dyslipidaemia guidelines - Lipid-lowering strategies.
Filmed on site at ESC 2019 by Radcliffe Cardiology.
| 1 session | |
| Lipid-lowering strategies | Watch now |
Part 2
Combination therapy
In this video, Prof François Mach (University of Geneva, CH) discusses dyslipidaemia guidelines - Combination therapy.
Filmed on site at ESC 2019 by Radcliffe Cardiology.
| 1 session | |
| Combination therapy | Watch now |
Part 3
Key updates
In this video, Dr Michel Farnier (Point Medical Clinic, Dijon, FR) discusses dyslipidaemia guidelines - What are the key updates?
Filmed on site at ESC 2019 by Radcliffe Cardiology.
| 1 session | |
| Key updates | Watch now |
Faculty Biographies
Michel Farnier
Dr Farnier is a Doctor of Medicine, a researcher and a teacher. His interests include dyslipidaemia, particularly its genetic aspects. He has conducted extensive research into type 2 diabetes and the development of new lipid-lowering drugs.